¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"Ç¥"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
Papanicolaou smear
ÆÄÆÄ´ÏÄÝ·ÎÆì¹Ù¸¥Ç¥º»
postaxial phocomelia
ÃàµÚ¹Ù´ÙÇ¥¹ü¹ßÁõ, ÃàµÚ´Ù¸®ÂªÀºÁõ
postsynaptic neuron
½Ã³À½ºÀÌÈĽŰ漼ǥ, ¿¬Á¢ÀÌÈĽŰ漼Æ÷
preparation
1. Áغñ 2. ¾àÁ¦, Á¦Àç 3. Á¶Á÷Ç¥º»
probability graph
È®·üµµÇ¥
probability sample
È®·üÇ¥º»
pseudoisochromatic plate
À¯»çµî»ö¼ºÆÇ, °¡¼ºµ¿»öÇ¥
pulmonary surfactant
ÆóÇ¥¸éȰ¼ºÁ¦, ÇãÆÄÇ¥¸éȰ¼ºÁ¦
parameter
1. ÁöÇ¥, ¸Å°³º¯¼ö, ÆÄ¶ó¹ÌÅÍ 2. °æ¼ö, ¸ð¼ö
parametric
1. ÀÚ±ÃÁÖÀ§- 2. ÁöÇ¥-
parametric test
ÁöÇ¥°ËÁ¤
percent labeled mitosis technique
¹éºÐÀ²Ç¥ÁöÀ¯»çºÐ¿¹ý
periderm
1. žÆÇ¥ÇÇ 2. ¹Ù±ùÇ¥ÇÇ
peripheral blood smear
¸»ÃÊÇ÷¾×Æì¹Ù¸¥Ç¥º»
permanent preparation
¿µ±¸Ç¥º»
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
15
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
epidermotrophism
Ç¥ÇÇÁöÇâ
epidermotrophic reticulosis
Ç¥ÇÇÁöÇâ±×¹°Áõ, Ç¥ÇÇÁöÇâ¼¼¸ÁÁõ
epidermatomycosis
Ç¥ÇÇÁø±ÕÁõ
interface dermatitis
Ç¥ÇÇÁøÇǰæ°è¸éÇǺο°
exfoliative toxin
Ç¥ÇÇÅ»¶ôµ¶¼Ò
transepidermal elimination
Ç¥ÇÇÅë°úÁ¦°Å
surface mold
Ç¥ÇÇÆ², Ç¥ÇÇÁÖÇü
Staphylococcus epidermidis
Ç¥ÇÇÆ÷µµ¾Ë±Õ
epidermal inclusion cyst
Ç¥ÇÇÆ÷ÇÔ³¶
epidermopoiesis
Ç¥ÇÇÇü¼º
epidermal dysplasia
Ç¥ÇÇÇü¼ºÀÌ»ó
epidermodysplasia
Ç¥ÇÇÇü¼ºÀÌ»ó
expression
Ç¥Çö, ¹ßÇö
expressivity
Ç¥Çöµµ
expressive skill
Ç¥Çö·Â, Ç¥Çö±â¼ú
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
surface law
üǥ¸é¹ýÄ¢
trace labeling
ÃßÀûÇ¥Áö
manifestation
¼Ò°ß, Ç¥Çö, Ç¥½Ã
milestone
ÀÌÁ¤Ç¥
monomeric
´ÜÀÎÀÚÇ¥Çö-
mucoepidermoid
Á¡¸·Ç¥ÇǸð¾ç-
maximum surgical blood order schedule
ÃÖ´ë¼ö¼úÇ÷¾×¿äû°èȹǥ, ÃÖ´ë¼ö¼úÇ÷¾×½Åû·®
microbiologic marker
¹Ì»ý¹°ÇÐÀûÇ¥ÁöÀÚ
molecular marker
ºÐÀÚÇ¥ÁöÀÚ
multitarget model
´ÙÇ¥Àû¸ðµ¨
multitarget multihit model
´ÙÇ¥Àû´ÙÀûÁ߸ðµ¨
multitarget single hit model
´ÙÇ¥Àû´ÜÀÏÀûÁ߸ðµ¨
risk marker
À§Ç赵ǥÁö
role model
¿ªÇÒÇ¥º»Çü
tumor marker
Á¾¾çÇ¥ÁöÀÚ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
15
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
leptocytes = target cell
Ç¥Àû»óÀûÇ÷±¸= Ç¥Àû¼¼Æ÷
leptocytosis
Ç¥Àû»óÀûÇ÷±¸Áõ°¡Áõ(?Ì¡?Ì¡).
leptocytosis
Ç¥Àû»óÀûÇ÷±¸Áõ°¡Áõ(¡ñòÊ¥ñø).
target glands
Ç¥Àû¼±(øöîÜàÍ).
cell, target
Ç¥Àû¼¼Æ÷
codocyte= target cell
Ç¥Àû¼¼Æ÷
target cell
Ç¥Àû¼¼Æ÷
targetoid hemosiderotic hemangioma
Ç¥Àû¾ç Çì¸ð½Ãµ¥¸° Ç÷°üÁ¾
target theory
Ç¥ÀûÀÌ·Ð
target organ
Ç¥ÀûÀå±â
critical organ
Ç¥ÀûÀå±â, À§ÇØÀå±â
target cell anemia
Ç¥ÀûÀûÇ÷?úÔºóÇ÷(øöîÜ îåúìϹàõÞ¸úì)
target cell anemia
Ç¥ÀûÀûÇ÷±¸¼º ºóÇ÷(øöîÜ îåúìϹàõÞ¸úì).
target tissue
Ç¥ÀûÁ¶Á÷(øöîÜðÚòÄ)
target skin distance=TSD
Ç¥ÀûÇǺΰŸ®
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
electron bleaching
ÀüÇØÇ¥¹é(ï³ú°ø÷ÛÜ).
electron microscopic autoradiography
µ¿À§¿ø¼ÒÇ¥Áö ÀüÀÚÇö¹Ì°æ¹ý
emotion, expressed(EE)
Ç¥Ãâ°¨Á¤
encephalitis haemorrhagica superior<³ª>
Ç¥À缺 ÃâÇ÷¼º ³ú¿°.
endometrial aspiration smear
Àڱ󻸷ÈíÀεµ¸»Ç¥º»(¡ÓóØÆøöÜâ).
endometriosis cutaneus
Ç¥À缺 Àڱ󻸷Áõ.
enzyme label(l)ing
È¿¼ÒÇ¥Áö.
enzyme labeled antibody
È¿¼ÒÇ¥ÁöÇ×ü.
enzyme labelling
È¿¼ÒÇ¥Áö
epicranial muscle<³ª> musculus epicranius
¸Ó¸®µ¤°³±Ù, µÎ°³Ç¥±Ù(ÔéËÏøúÐÉ).
epiderm = epidermis
Ç¥ÇÇ(øúù«)
epiderm =epidermis
Ç¥ÇÇ(øúù«).
epidermabrasion
Ç¥ÇÇ ¹ÚÇǼú
epidermal
Ç¥ÇǼº(øúù«àõ)ÀÇ
epidermal abundance
Ç¥Çǰú´Ù
ÀÌÀü
´ÙÀ½
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú :
5
ÆäÀÌÁö:
11
ÄÚµå
¿µ¹®
ÇѱÛ
T32.7
Corrosions involving 70-79£¥ of body surface
½Åüǥ¸éÀÇ 70-79£¥¸¦ Æ÷ÇÔÇÑ ºÎ½Ä
T32.8
Corrosions involving 80-89£¥ of body surface
½Åüǥ¸éÀÇ 80-89£¥¸¦ Æ÷ÇÔÇÑ ºÎ½Ä
T32.9
Corrosions involving 90£¥ or more of body surface
½Åüǥ¸éÀÇ 90£¥ ÀÌ»óÀ» Æ÷ÇÔÇÑ ºÎ½Ä
T95.4
Sequelae of burn and corrosion classifiable only according to extent of body surface involved
ħ¹üµÈ ½Åüǥ¸éÀÇ Á¤µµ¿¡ µû¶ó¼¸¸ ºÐ·ù °¡´ÉÇÑ È»ó ¹× ºÎ½ÄÀÇ ÈÄÀ¯Áõ
Z60.5
Target of perceived adverse discrimination and persecution
À¯ÇØÇÑ Â÷º° ¹× ¹ÚÇØ¸¦ ¹Þ´Â ¸ñÇ¥¹°
ÀÌÀü
´ÙÀ½
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
¼³¸í
safty standard
¾ÈÀü Ç¥ÁØ
sample design
Ç¥º» ¼³°è
sample preservation
Ç¥º» º¸Á¸
µµ¸» ÈÄ »¡¸® ¿°»öÇÏ¿© º¸Á¸ÇÏ´Â °ÍÀ¸·Î¼, ½Ã°£ÀÌ °æ°úÇÏ¸é ¿°»ö¼ºÀÌ ÀúÇϵȴÙ.
sampling error
Ç¥º» ¿ÀÂ÷
Ç¥º» µ¥ÀÌŸ·ÎºÎÅÍ °è»êµÈ ¸ð¼ö ÃßÁ¤Ä¡¿Í ¸ð¼öÀÇ Â÷ÀÌ.
sampling inspection
Ç¥º» ÃßÃâ °Ë»ç
sampling number
Ç¥º» ÃßÃâ ¼ö
scalded skin syndrome
Ç¥ÇÇ ¹Ú¸® ÁõÈıº
Ȳ»ö Æ÷µµ ±¸±ÕÀÇ Ç¥ÇÇ ¹Ú¸® µ¶¼Ò¿¡ ÀÇÇÑ ÇǺκ´À¸·Î, ÀÌ ÁúȯÀÇ ÀÓ»ó Áõ»óÀº ÀÌ µ¶¼Ò¿¡ ±âÀÎÇϸç Ȳ»ö Æ÷µµ ±¸±Õ °¨¿° ±× ÀÚü¿¡ ÀÇÇÑ ¿µÇâ°ú´Â ±¸ºÐµÈ´Ù. 3°¡Áö ÀÓ»óÀû Áõ»óÀ¸·Î´Â, Àü½Å¼º Ç¥¸® ¹Ú¸®¼º ÇǺο°, Bullous im
scheme
°èȹ, µµÇ¥, µµ½Ä
smeary
µµ¸» Ç¥º»ÀÇ
specimen
°Ëü, Ç¥º», °Ë»ç¹°
1. ¿äÀÇ °Ëü¿Í °°ÀÌ ÀüüÀÇ ¼ºÁúÀ» ³ªÅ¸³»°Å³ª ¶Ç´Â °áÁ¤Çϱâ À§Çؼ äÃëÇÑ ÇÑ °³ ¶Ç´Â ¿©·¯ °³ ¹°ÁúÀÇ Ç¥º». 2. º´¸®ÇÐÀû °Ë»ç¸¦ À§ÇÑ Á¶Á÷Ç¥º» ¶Ç´Â ±× ±¸Á¶¸¦ ¿¬±¸Çϱâ À§ÇÑ Á¤»ó Á¶Á÷. ±â°ü ¶Ç´Â ¼¼±ÕÀÇ Ç¥º».
standard
Ç¥ÁØ, ±âÁØ
standard consistency
Ç¥ÁØ Á¡Á¶µµ
standard dosing :
standard error
Ç¥ÁØ ¿ÀÂ÷
standard illuminant
Ç¥ÁØ ±¤¿ø
»ó´ëÀûÀÎ Èû ºÐ»ê °î¼±ÀÇ ¿ë¾î·Î CIE¿¡ ÀÇÇØ A,B,C,D·Î Á¤ÀǵǴ ±¤¿ø.
standard light source
Ç¥ÁØ ±¤¿ø
½ºÆåÆ®·³ ºÐ»ê·ÂÀÌ ¾Ë·ÁÁø ±âÁØ ±¤¿ø.
ÀÌÀü
´ÙÀ½
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú :
12
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
expression
Ç¥Çö,¹ßÇ¥,Ç¥Á¤
representation
Ç¥Çö; ÁÖÀå; Ç×ÀÇ; ´ëÇ¥´Ü
expression
Ç¥Çö;¸»Åõ;Ç¥Á¤
unexpressive
Ç¥Çö·ÂÀÌ ºÎÁ·ÇÑ;¶æÀ» ÃæºÐÈ÷ Àü´ÞÇÏÁö ¸øÇÏ´Â
phenetics
Ç¥Çö·ÐÀû ºÐ·ù !
expressional
Ç¥Çö»óÀÇ;Ç¥Á¤ÀÇ
expressionism
Ç¥ÇöÁÖÀÇ;Ç¥Çö°ú
expressionistic
Ç¥ÇöÁÖÀÇÀûÀÎ
expressive
Ç¥ÇöÇÏ´Â;ÀÇ¹Ì ½ÉÀåÇÑ;Ç¥Á¤ÀÌ Ç³ºÎÇÑ;Ç¥ÇöÀÇ
express
Ç¥ÇöÇÏ´Ù;Ç¥½ÃÇÏ´Ù;Áö±ÞÆíÀ¸·Î º¸³»´Ù;¸í½ÃµÈ;¸í¹éÇÑ;Á¤È®ÇÑ;Ưº°ÇÑ;±ÞÇàÀÇ;Áö±ÞÆíÀÇ;¿î¼ÛÆíÀÇ;Ưº°È÷;±ÞÇàÀ¸·Î;¼Ó´Þ·Î;Áö±ÞÆí;Ưº°Æí;±ÞÇà¿Â÷;¿î¼Ûȸ»ç
expressible
Ç¥ÇöÇÒ ¼ö ÀÖ´Â;Â¥³¾ ¼ö ÀÖ´Â
phenotype
Ç¥ÇöÇü;ȯ°æ¿¡ µû¶ó ¿ÜºÎ¿¡ ³ªÅ¸³ª´Â
ÀÌÀü
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
wellturned
±³¹¦È÷ Ç¥ÇöµÈ
yardstick
Ç¥ÁØ
-er
(µ¿»ç¿Í ¸í»ç¿¡¼ µ¿ÀÛÀÚ)¸í»ç¸¦ ¸¸µë;...ÇÏ´Â °Í;¹Ýº¹À» Ç¥½ÃÇÏ´Â µ¿»ç¸¦ ¸¸µê
Addressograph
=ADDRESSING MACHINE(»óÇ¥¸í)
All American
Àü¹Ì´ëÇ¥ÀÇ;¹Ì±¹ÀÎÀ¸·Î¸¸ µÈ;¹Ì±¹Á¦ÀÏÀÇ(»ç¶÷)
Amytal
¾Æ¹ÌÅ»(ÁøÁ¤Á¦,»óÇ¥¸í)
Antiphlogistine
¼Ò¿°°í(»óÇ¥¸í)
Argyrol
ÇÔÀº¾×;¹æºÎ¿ëÀ¸·Î »ç¿ë;»óÇ¥¸í
Atticism
¾ÆÅ׳×ÀÎ ¾ÖÈ£;¾ÆÅ×³× ¹®ÇÐÀÇ Æ¯Áú;¾ÆÅ×³× Æ¯À¯ÀÇ ¸»;°£°áÇÏ°í ¿ì¾ÆÇÑ Ç¥Çö
Aunt Sally
ÆÄÀÌÇÁ¸¦ ¶³¾î¶ß¸®´Â ³îÀÌ;Ç¥Àû
Banthine
¹ê½Å(À§±Ë¾ç Ä¡·áÁ¦,»óÇ¥¸í)
Barrie
¹è¸® Sir James M;~(1860-1937)(¿µ±¹ÀÇ ¼Ò¼³°¡,±ØÀÛ°¡,´ëÇ¥ÀÛ Peter Pan)
Benlate
º¥·¹ÀÌÆ®(»ì±Õ¿ë ³ó¾à,»óÇ¥¸í)
Big Board
´º¿å Áõ±Ç °Å·¡¼Ò(»óÀåÀÇ ÁÖ½Ç ½Ã¼¼Ç¥)
Black Panther
°ËÀº Ç¥¹ü(¹Ì±¹ÀÇ ÈæÀÎ °ú°ÝÆÄ ´ç¿ø)
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
Á¦Ç°¸í
¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
ÀÌÀü
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
Á¦Ç°¸í
¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
ÀÌÀü
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
ÀÌÀü
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
ÀÌÀü
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
ÇÑÀÚ
ÀÌÀü
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
ÇÑÀÚ
ÀÌÀü
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑ»ýÈÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑ»ýÈÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
ÀÌÀü
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
ÀÌÀü
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
ÀÌÀü
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
ÀÌÀü
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
ÀÌÀü
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
ÄÚµå
¿µ¹®
ÇѱÛ
ÀÌÀü
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
¼³¸í
ÀÌÀü
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú:
0
ÆäÀÌÁö:
11
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå
¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
ÀÌÀü
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú:
0
ÆäÀÌÁö:
11
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå
¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½